College of Pharmaceutical Sciences, Southwest University, Chongqing 400715, PR China.
College of Chemistry and Chemical Engineering, Huaiyin Normal University, Huai'an 223300, PR China.
Gene. 2019 Aug 15;709:8-16. doi: 10.1016/j.gene.2019.04.079. Epub 2019 May 25.
Aureobasidium pullulans, a yeast-like fungus with strong environmental adaptability, remains a potential host for bio-production of different valuable metabolites. However, its potential application is limited by low-efficient genetic manipulation. In this study, CRISPR/Cas9-mediated genome editing via protoplast-based transformation system was developed. To test CRISPR/Cas9 mediated genomic mutagenesis, the orotidine 5-phosphate decarboxylase (umps) gene was used as a counter-selectable selection marker. By co-transforming of two plasmids harboring cas9 gene and a guide RNA targeting umps, respectively, the CRISPR/Cas9 system could significantly increase frequency of mutation in the targeting site of guide RNA. To further validate that CRISPR/Cas9 stimulated homologous recombination with donor DNA, a color reporter system of beta-glucuronidase (gus) gene was developed for calculating positive mutation rate. The results showed that positive mutation rate with CRISPR/Cas9 system was 40% significantly higher than only with the donor DNA (4%). Furthermore, the different posttranscriptional RNA processing schemes were analyzed by compared the effects of flanking gRNA with self-cleaving ribozymes or tRNA. The result demonstrated that gRNA processed by self-cleaving ribozymes achieves higher positive mutant rate. This study provided foundation for a simple and powerful genome editing tool for A. pullulans. Moreover, a counter-selectable selection marker (umps) and a color reporter system (gus) were being developed as genetic parts for strain engineering.
出芽短梗霉是一种具有很强环境适应性的酵母样真菌,仍然是生物生产不同有价值代谢物的潜在宿主。然而,其潜在应用受到低效率遗传操作的限制。在本研究中,通过原生质体转化系统建立了 CRISPR/Cas9 介导的基因组编辑。为了测试 CRISPR/Cas9 介导的基因组诱变,使用乳清酸 5-磷酸脱羧酶 (umps) 基因作为可选择的选择标记。通过共转化分别携带 cas9 基因和靶向 umps 的向导 RNA 的两个质粒,CRISPR/Cas9 系统可以显著增加靶向向导 RNA 位点的突变频率。为了进一步验证 CRISPR/Cas9 刺激同源重组与供体 DNA,开发了β-葡聚糖酶 (gus) 基因的显色报告系统,用于计算阳性突变率。结果表明,CRISPR/Cas9 系统的阳性突变率约为 40%,显著高于仅使用供体 DNA(约 4%)。此外,通过比较侧翼 gRNA 与自我切割核酶或 tRNA 的作用,分析了不同的转录后 RNA 处理方案。结果表明,自我切割核酶处理的 gRNA 可实现更高的阳性突变率。这项研究为出芽短梗霉提供了一种简单而强大的基因组编辑工具。此外,正在开发可选择的选择标记(umps)和显色报告系统(gus)作为菌株工程的遗传元件。